About Numiera Therapeutics Numiera is a preclinical-stage pharmaceutical company focused on developing small-molecule ...

By adding Canada and the entire Latin America region, including Mexico, WODA completes its full global commercialization offering for rare and specialty therapies.With two new members - Innovative ...

Numiera Therapeutics Inc., a client company of Fort Collins-based Innosphere and a pharmaceutical pioneer in small-molecule ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.

From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian ...

There has been a significant increase in orphanhood in the last two decades in the U.S., according to a new study. The ...

Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC. Click here to find out why I ...

As previously announced on December 13, Diamyd Medical had held a positive in-person meeting with the FDA. Following the meeting, Diamyd Medical has now received the final minutes. The FDA provided ...

Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration ...